Human papillomavirus type 16 E5 protein inhibits hydrogen peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells

Carcinogenesis

Volumn 31, Issue 3, 2010, Pages 402-410

  Oh, Jung Min ^a   Kim, Su Hyeong ^a   Cho, Eun Ah ^a   Song, Yong Sang ^a   Kim, Woo Ho ^a   Juhnn, Yong Sung ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLOOXYGENASE 2; E5 PROTEIN; HYDROGEN PEROXIDE; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROTEASOME; PROTEIN BAX; SMALL INTERFERING RNA; UBIQUITIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 6-ISOPROPOXY-9-OXOXANTHENE-2-CARBOXYLIC ACID; 7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; ANDROSTANE DERIVATIVE; BAX PROTEIN, HUMAN; BIPHENYL DERIVATIVE; CYCLOHEXIMIDE; CYCLOOXYGENASE 2 INHIBITOR; ISOQUINOLINE DERIVATIVE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; ONCOGENE PROTEIN E5, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2 RECEPTOR, EP4 SUBTYPE; PROSTAGLANDIN EP2 RECEPTOR; PTGS2 PROTEIN, HUMAN; SULFONAMIDE; TUMOR PROTEIN; WORTMANNIN; XANTHONE DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RNA INTERFERENCE; SENSITIZATION; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

ANDROSTADIENES; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BIPHENYL COMPOUNDS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOHEXIMIDE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; FEMALE; HUMANS; HYDROGEN PEROXIDE; ISOQUINOLINES; NEOPLASM PROTEINS; ONCOGENE PROTEINS, VIRAL; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, PROSTAGLANDIN E; RNA, SMALL INTERFERING; SULFONAMIDES; UBIQUITIN; UTERINE CERVICAL NEOPLASMS; XANTHONES;

EID: 77950905948     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp318     Document Type: Article

References (46)

1. zur Hausen, H. (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev., 2, 342-350.
2. Woodman, C.B. et al. (2007) The natural history of cervical HPV infection: unresolved issues. Nat. Rev., 7, 11-22.
3. Scheffner, M. et al. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63, 1129-1136.
4. Munger, K. et al. (2001) Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene, 20, 7888-7898.
5. Conrad, M. et al. (1993) The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16kilodalton pore-forming protein. J. Virol., 67, 6170-6178.
6. Pim, D. et al. (1992) Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene, 7, 27-32.
7. Straight, S.W. et al. (1993) The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J. Virol., 67, 4521-4532.
8. Stoppler, M.C. et al. (1996) The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA. Virology, 223, 251-254.
9. Leechanachai, P. et al. (1992) The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene, 7, 19-25.
10. Genther Williams, S.M. et al. (2005) Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res., 65, 6534-6542.
11. Maufort, J.P. et al. (2007) Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis. Cancer Res., 67, 6106-6112.
12. Tomakidi, P. et al. (2000) Modulation of the epidermal growth factor receptor by the human papillomavirus type 16 E5 protein in raft cultures of human keratinocytes. Eur. J. Cell Biol., 79, 407-412.
13. Mates, J.M. et al. (2008) Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis. Arch. Toxicol., 82, 273-299.
14. Kabsch, K. et al. (2002) The human papillomavirus type 16 E5 protein impairs TRAILand FasL-mediated apoptosis in HaCaT cells by different mechanisms. J. Virol., 76, 12162-12172.
15. Kabsch, K. et al. (2004) The HPV-16 E5 protein inhibits TRAILand FasLmediated apoptosis in human keratinocyte raft cultures. Intervirology, 47, 48-56.
16. Zhang, B. et al. (2002) E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis. J. Virol., 76, 220-231.
17. Yee, C. et al. (1985) Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol., 119, 361-366.
18. Siadat-Pajouh, M. et al. (1994) Introduction of a fast and sensitive fluorescent in situ hybridization method for single-copy detection of human papillomavirus (HPV) genome. J. Histochem. Cytochem., 42, 1503-1512.
19. Oh, J.M. et al. (2009) Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells. Carcinogenesis, 30, 141-149.
20. Rhim, J.S. et al. (1985) Neoplastic transformation of human epidermal keratinocytes by AD12-SV40 and Kirsten sarcoma viruses. Science, 227, 1250-1252.
21. Li, B. et al. (2000) Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. Proc. Natl Acad. Sci. USA, 97, 3850-3855.
22. Choi, W.S. et al. (2001) Cleavage of Bax is mediated by caspase-dependent or - independent calpain activation in dopaminergic neuronal cells: protective role of Bcl-2. J. Neurochem., 77, 1531-1541.
23. Gorman, A. et al. (1997) Role of peroxide and superoxide anion during tumour cell apoptosis. FEBS Lett., 404, 27-33.
24. Pelicano, H. et al. (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist. Updat., 7, 97-110.
25. Kabsch, K. et al. (2002) The human papillomavirus type 16 (HPV-16) E5 protein sensitizes human keratinocytes to apoptosis induced by osmotic stress. Oncogene, 21, 947-953.
26. Youle, R.J. et al. (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol., 9, 47-59.
27. Oltvai, Z.N. et al. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74, 609-619.
28. Newmeyer, D.D. et al. (2003) Mitochondria: releasing power for life and unleashing the machineries of death. Cell, 112, 481-490.
29. Chipuk, J.E. et al. (2006) Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ., 13, 1396-1402.
30. Rampino, N. et al. (1997) Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science, 275, 967-969.
31. Miquel, C. et al. (2005) Role of bax mutations in apoptosis in colorectal cancers with microsatellite instability. Am. J. Clin. Pathol., 123, 562-570.
32. Harima, Y. et al. (1998) Bax and Bcl-2 expressions predict response to radiotherapy in human cervical cancer. J. Cancer Res. Clin. Oncol., 124, 503-510.
33. Sultana, H. et al. (2003) Chemosensitivity and p53-Bax pathway-mediated apoptosis in patients with uterine cervical cancer. Ann. Oncol., 14, 214-219.
34. Krajewski, S. et al. (1995) Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res., 55, 4471-4478.
35. Fecker, L.F. et al. (2006) Loss of proapoptotic Bcl-2-related multidomain proteins in primary melanomas is associated with poor prognosis. J. Invest. Dermatol., 126, 1366-1371.
36. Ciechanover, A. (1994) The ubiquitin-proteasome proteolytic pathway. Cell, 79, 13-21.
37. Zhang, H.G. et al. (2004) Regulation of apoptosis proteins in cancer cells by ubiquitin. Oncogene, 23, 2009-2015.
38. Yu, M. et al. (2008) The alpha-5 helix of Bax is sensitive to ubiquitindependent degradation. Biochem. Biophys. Res. Commun., 371, 10-15.
39. Agrawal, S.G. et al. (2008) Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia. Blood, 111, 2790-2796.
40. Liu, F.T. et al. (2008) Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL. Blood, 111, 2797-2805.
41. Vogt, M. et al. (2006) Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein. Oncogene, 25, 4009-4015.
42. Kim, M.J. et al. (2006) Protection from apoptotic cell death by cilostazol, phosphodiesterase type III inhibitor, via cAMP-dependent protein kinase activation. Pharmacol. Res., 54, 261-267.
43. Cho, Y.S. et al. (2002) Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation. Clin. Cancer Res., 8, 607-614.
44. Martin, A.C. et al. (2006) Layers of organization of cAMP microdomains in a simple cell. Biochem. Soc. Trans., 34, 480-483.
45. Daniel, P.B. et al. (1998) Cyclic AMP signaling and gene regulation. Annu. Rev. Nutr., 18, 353-383.
46. Oetke, C. et al. (2000) Human papillomavirus type 16 E5 protein localizes to the Golgi apparatus but does not grossly affect cellular glycosylation. Arch. Virol., 145, 2183-2191.